Investing

First Look Analyst Calls Briefing for Monday, October 31, 2022 

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today.

Upgrades:

> BioMarin Pharmaceutical (BMRN) upgraded to Outperform from Perform at Oppenheimer; tgt raised to $110

> Cullen/Frost (CFR) upgraded to In-line from Underperform at Evercore ISI; tgt raised to $160

Downgrades:

> ABB Ltd (ABB) downgraded to Buy from Conviction Buy at Goldman

> Advanced Micro (AMD) downgraded to Market Perform from Outperform at Northland Capital; tgt lowered to $60

> Ameris Bancorp (ABCB) downgraded to Mkt Perform from Outperform at Raymond James

> Aon (AON) downgraded to Underperform from Mkt Perform at Raymond James

Others:

> Ares Commercial Real Estate (ACRE) resumed with a Buy at BofA Securities; tgt $13

> Business First Bancshares (BFST) initiated with an Outperform at Raymond James; tgt $28

Essential Tips for Investing (Sponsored)

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.